Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-09-29 Sale | 2023-10-05 5:16 pm | Celularity Inc | CELU | Sorrento Therapeutics Inc. 10% Owner | 15,371,697 | $0 | $0 | 5,050,427 (Direct) | View |
2023-09-21 Sale | 2023-09-25 4:27 pm | Scilex Holding Co | SCLX | Sorrento Therapeutics Inc. 10% Owner | 60,068,585 | $0 | $0 | 1,917,210 (Direct) | View |
2021-03-15 Sale | 2023-02-06 9:10 pm | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 3,000 | $10.42 | $31,273 | 0 (Direct) | View |
2022-09-07 Purchase | 2022-09-07 6:22 pm | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 88,888 | $2.0177 | $179,349 | 7,078,386 (Indirect Direct) | View |
2022-09-06 Purchase | 2022-09-06 5:24 pm | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 55,555 | $1.9599 | $108,882 | 6,988,610 (Indirect Direct) | View |
2022-08-26 Purchase | 2022-08-26 5:33 pm | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 33,333 | $2.11 | $70,333 | 4,433,255 (Indirect Direct) | View |
2022-08-25 Purchase | 2022-08-25 5:18 pm | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 22,222 | $2.0596 | $45,768 | 4,400,722 (Indirect Direct) | View |
2022-06-14 Purchase | 2022-06-14 5:15 pm | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 10,000 | $1.3999 | $13,999 | 4,377,500 (Indirect Direct) | View |
2021-12-27 Sale | 2021-12-27 7:34 pm | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 3,000 | $5.88 | $17,640 | 3,000 (Direct) | View |
2021-09-27 Sale | 2021-09-28 5:37 pm | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 42,357 | $8.0204 | $339,720 | 30,643 (Direct) | View |
2021-09-13 Sale | 2021-09-14 5:00 pm | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 8,000 | $8.0356 | $64,285 | 3,000 (Direct) | View |
2021-04-12 Sale | 2021-04-15 6:43 pm | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 1,900 | $6.9742 | $13,251 | 3,000 (Direct) | View |
2020-12-16 Sale | 2021-01-26 5:24 pm | Sorrento Therapeutics Inc. | SRNE | Followwill Dorman Director | 1,000 | $7.135 | $7,135 | 2,130 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-17 Disposition | 2023-03-20 7:52 pm | 2022-08-26 2023-03-17 | Sorrento Therapeutics Inc. | SRNEQ | Ji Henry See Remarks | 195 | $0 | 8,597,498 (Indirect) | View |
2023-03-17 Exercise | 2023-03-20 7:52 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNEQ | Ji Henry See Remarks | 19,500 | $0.8027 | 8,597,498 (Indirect) | View |
2023-01-19 Other | 2023-01-23 4:11 pm | N/A N/A | Scilex Holding Co | SCLX | Sorrento Therapeutics Inc. 10% Owner | 73,740,795 | $0 | 135,726,590 (Direct) | View |
2022-12-02 Exercise | 2022-12-23 2:28 pm | 2022-08-26 2023-03-17 | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 5 | $0 | 8,578,391 (Indirect) | View |
2022-12-02 Exercise | 2022-12-23 2:28 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 500 | $5.5 | 8,578,391 (Indirect) | View |
2022-12-15 Option Award | 2022-12-16 8:10 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 1,500,000 | $0 | 8,577,498 (Direct) | View |
2022-11-10 Other | 2022-11-15 6:38 pm | 2022-11-10 2027-11-10 | Vickers Vantage Corp. I | SCLX | Sorrento Therapeutics Inc. 10% Owner | 3,104,000 | $0 | 5,900,704 (Direct) | View |
Ownership | 2022-11-15 6:27 pm | N/A N/A | Vickers Vantage Corp. I | SCLX | Sorrento Therapeutics Inc. 10% Owner | 0 | $0 | 164,783,687 (Direct) | View |
2022-09-02 Option Award | 2022-09-02 4:31 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 2,500,000 | $0 | 6,933,055 (Direct) | View |
2022-05-18 Option Award | 2022-05-20 5:14 pm | N/A 2032-05-18 | Sorrento Therapeutics Inc. | SRNE | CZEREPAK ELIZABETH EVP & Chief Financial Officer | 350,000 | $0 | 350,000 (Direct) | View |
2022-05-18 Option Award | 2022-05-20 5:11 pm | N/A 2032-05-18 | Sorrento Therapeutics Inc. | SRNE | Reilly Tammy Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-12-27 Exercise | 2021-12-27 7:34 pm | 2013-01-01 2022-02-06 | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 3,000 | $0 | 3,000 (Direct) | View |
2021-12-27 Exercise | 2021-12-27 7:34 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 3,000 | $4 | 3,000 (Direct) | View |
2021-11-18 Option Award | 2021-11-18 5:11 pm | N/A 2031-11-18 | Sorrento Therapeutics Inc. | SRNE | CZEREPAK ELIZABETH Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-09-29 Exercise | 2021-09-29 2:35 pm | N/A 2022-02-06 | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 10,000 | $0 | 4,367,500 (Direct) | View |
2021-09-29 Exercise | 2021-09-29 2:35 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 10,000 | $4 | 4,367,500 (Direct) | View |
2021-09-27 Exercise | 2021-09-28 5:37 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 7,357 | $3.57 | 30,643 (Direct) | View |
2021-09-27 Exercise | 2021-09-28 5:37 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 35,000 | $1.8 | 30,643 (Direct) | View |
2021-09-27 Exercise | 2021-09-28 5:37 pm | N/A 2027-09-15 | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 42,357 | $0 | 30,643 (Direct) | View |
2021-09-13 Exercise | 2021-09-14 5:00 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 8,000 | $3.5 | 3,000 (Direct) | View |
2021-09-13 Exercise | 2021-09-14 5:00 pm | N/A 2021-09-28 | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 8,000 | $0 | 3,000 (Direct) | View |
2021-09-03 Exercise | 2021-09-03 5:36 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director | 75,000 | $3.95 | 235,000 (Direct) | View |
2021-09-03 Exercise | 2021-09-03 5:36 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director | 100,000 | $4.89 | 235,000 (Direct) | View |
2021-09-03 Exercise | 2021-09-03 5:36 pm | N/A 2029-12-16 | Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director | 175,000 | $0 | 235,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:16 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks | 2,500,000 | $0 | 2,500,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:16 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | Wu Yue Alexander Director | 250,000 | $0 | 250,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:15 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director | 250,000 | $0 | 250,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:14 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | SHAH JAISIM Director | 250,000 | $0 | 250,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:13 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | Lemus David Director | 250,000 | $0 | 250,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:13 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 250,000 | $0 | 250,000 (Direct) | View |
2021-08-30 Option Award | 2021-08-30 8:12 pm | N/A 2031-08-30 | Sorrento Therapeutics Inc. | SRNE | Followwill Dorman Director | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2021-07-23 06:04 am | N/A N/A | Celularity Inc | CELU | Sorrento Therapeutics Inc. 10% Owner | 0 | $0 | 20,422,124 (Direct) | View |
2021-04-12 Exercise | 2021-04-15 6:43 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 1,900 | $3.5 | 3,000 (Direct) | View |
2021-04-12 Exercise | 2021-04-15 6:43 pm | 2012-04-15 2021-04-15 | Sorrento Therapeutics Inc. | SRNE | Janda Kim Director | 1,900 | $0 | 3,000 (Direct) | View |
2021-03-16 Option Award | 2021-03-17 4:57 pm | N/A 2031-03-16 | Sorrento Therapeutics Inc. | SRNE | Asghar Najjam Chief Financial Officer | 156,974 | $0 | 156,974 (Direct) | View |
2020-11-11 Acquisition | 2021-01-26 5:24 pm | N/A N/A | Sorrento Therapeutics Inc. | SRNE | Followwill Dorman Director | 1,000 | $0 | 2,130 (Direct) | View |